Gujarat Kidney & Super Speciality IPO

Gujarat Kidney IPO is a book-building issue of ₹250.80 cr, which is entirely a fresh issue. The IPO price band is set at ₹108 to ₹114 per share and the minimum amount of investment required by an individual investor is ₹14,592 (128 shares), which will be listed on the platforms BSE, NSE with a tentative listing date. The lot size for an application is 128. The IPO subscription will open on December 22, 2025 and closes on December 24, 2025.

Company Background

Gujarat Kidney and Super Speciality Ltd. was incorporated in 2019. It is a leading healthcare central region in Gujarat, offering comprehensive multispeciality services across secondary and tertiary care. The company operates seven hospitals and four pharmacies, with a total bed capacity of 490, supporting advanced medical care across Vadodara, Godhra, Bharuch, Borsad and Anand. These hospitals provide a wide range of services, including general and surgical treatments, super speciality procedures, orthopaedics, joint replacement, obstetrics and gynaecology, cardiology and diabetology. As of June 30, 2025, their team comprised 89 doctors, 332 nurses and 338 support staff, delivering high-quality patient care across multiple locations.

Operations and Product Range

Facility and Production

They operate multispeciality hospitals and pharmacies across Gujarat, with a total bed capacity of 490 (340 operational). The facilities provide secondary and tertiary care, including super-speciality surgeries, orthopaedics, cardiology, joint replacement, and obstetrics. Supported by 89 doctors, 332 nurses, and 338 staff, the hospitals ensure high-quality patient care.

Brands and Market Presence

This company has established a strong presence in Gujarat’s healthcare sector through its seven hospitals and four pharmacies. Operating under well-recognised names like Gujarat Kidney and Superspeciality Hospital and Ashwini Medical Centre, the company delivers trusted secondary and tertiary care, building a reputable brand across multiple cities and enhancing accessibility to quality healthcare.

Revenue Channels

• • Fee from the patient care service, including general and speciality surgery treatment.
• • Fees from diagnostic and laboratory services.
• • Sale revenue through company-operated pharmacies.

Management and Shareholding

Promoters and Shareholding

The promoters and shareholders are experienced healthcare professionals and business leaders committed to expanding quality healthcare services in Gujarat. The promoters hold a significant stake in the company, ensuring strategic control and long-term vision, while the remaining shareholding may include institutional investors, private investors and other stakeholders supporting the company’s growth and operations.

Board Members

The board members of this company comprise experienced professionals from healthcare, management, and finance domains. They provide strategic guidance, oversee corporate governance and drive the company’s growth and operational excellence. Also, the promoters, along with independent directors who ensure compliance, transparency and sustainable development across all hospital and pharmacy operations.